Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-11
DOI
10.3389/fcell.2019.00233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive cell transfer therapy for hepatocellular carcinoma
- (2019) Renyu Zhang et al. Frontiers of Medicine
- Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life
- (2019) Daneng Li et al. Cancers
- Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019
- (2019) Francesco Tovoli et al. DIGESTIVE AND LIVER DISEASE
- Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
- (2019) Shengnan Yu et al. Molecular Cancer
- A guide to manufacturing CAR T cell therapies
- (2018) Philipp Vormittag et al. CURRENT OPINION IN BIOTECHNOLOGY
- Recent developments with immunotherapy for hepatocellular carcinoma
- (2018) Oliver Waidmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress
- (2018) Meng Lu et al. HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager
- (2018) Anna Wing et al. Cancer Immunology Research
- Review article: systemic treatment of hepatocellular carcinoma
- (2018) Matthias Pinter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
- (2018) Anna C. Filley et al. Frontiers in Oncology
- Functional role of CCL5/RANTES for HCC progression during chronic liver disease
- (2017) Antje Mohs et al. JOURNAL OF HEPATOLOGY
- T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
- (2017) Robert Sackstein et al. LABORATORY INVESTIGATION
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Current status and future prospects of the strategy of combining CAR‑T with PD‑1 blockade for antitumor therapy (Review)
- (2017) Jinjing Xu et al. Molecular Medicine Reports
- Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
- (2017) Silvia Arcangeli et al. MOLECULAR THERAPY
- Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours
- (2017) J. Justin Milner et al. NATURE
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
- (2017) Hua Li et al. Protein & Cell
- Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
- (2017) Zhiwu Jiang et al. Frontiers in Immunology
- Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
- (2016) Cheng Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells
- (2016) J Wu et al. ONCOGENE
- Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
- (2015) X. Liu et al. CANCER RESEARCH
- Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
- (2015) H. G. Caruso et al. CANCER RESEARCH
- The yin and yang of evasion and immune activation in HCC
- (2015) Oxana V. Makarova-Rusher et al. JOURNAL OF HEPATOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- The Changing Landscape of Hepatocellular Carcinoma
- (2014) Erik S. Knudsen et al. AMERICAN JOURNAL OF PATHOLOGY
- Management of hepatocellular carcinoma
- (2014) P. Fitzmorris et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Trial of [131I] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation
- (2014) Huijie Bian et al. JNCI-Journal of the National Cancer Institute
- The inducible caspase-9 suicide gene system as a “safety switch†to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
- (2014) Tessa Gargett et al. Frontiers in Pharmacology
- Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells Is Required for Their Migration into Tumors To Elicit Effective Antitumor Immunity
- (2013) R. K. Sharma et al. JOURNAL OF IMMUNOLOGY
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
- (2012) Christopher C Kloss et al. NATURE BIOTECHNOLOGY
- Immunotherapy of hepatocellular carcinoma
- (2012) Angela D. Pardee et al. OncoImmunology
- Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice
- (2011) Ana Caterina Parente-Pereira et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Improved Tet-responsive promoters with minimized background expression
- (2010) Rainer Loew et al. BMC BIOTECHNOLOGY
- HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection
- (2009) Yu Li et al. HISTOPATHOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started